Intestinal permeability in colorectal cancer patients treated by raltitrexed or irinotecan [1]

Journal of Clinical Gastroenterology

Volumn 37, Issue 2, 2003, Pages 192-193

  Melichar, Bohuslav ^a   Dvořák, Josef ^a   Kohout, Pavel ^a   Melicharová, Karolina ^a   Solichová, Dagmar ^a   Zadák, Zdeněk ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CELLOBIOSE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LACTULOSE; MANNITOL; RALTITREXED; XYLOSE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG MECHANISM; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE MUCOSA PERMEABILITY; LETTER; MALABSORPTION; MALE; MUCOSA INFLAMMATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SMALL INTESTINE DISEASE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PERMEABILITY; QUINAZOLINES; THIOPHENES;

EID: 0037706979     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200308000-00021     Document Type: Letter

References (9)

1. Cunningham D, Zalcberg J, Maroun J, et al. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials. Eur J Cancer. 2002;38:478-486.
2. Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing Tomudex (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Ann Oncol. 1996;7:961-965.
3. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385-396.
4. Kohout P, Cerman J, Bratova M, et al. Small bowel permeability in patients with cytostatic therapy. Nutrition. 1999;15:546-549.
5. Daniele B, Secondulfo M, De Vivo R, et al. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol. 2001;32:228-230.
6. Daniele B, Perron F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28-33.
7. Melichar B, Kohout P, Bratova M, et al. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol. 2001;127:314-318.
8. Craig RM, Ehrenpreis ED. D-xylose testing. J Clin Gastroenterol. 1999;29:143-150.
9. Takasuna K, Hagiwara T, Hirohashi M, et al. Involvement of beta-glucoronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res. 1996;56:3752-3757.